A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced adenocarcinoma of the pancreas
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: N. B. Connolly, D. Shaw, J. Fenemore, C. Garner, S. Kilany, G. Hedlund, G. Forsberg, P. Stern, R. E. Hawkins
Institution: The Christie Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1899577508
